Emerging drugs for cystic fibrosis

Abstract excerpt

INTRODUCTION: Cystic fibrosis is an autosomal recessive disease, which is the result of a genetic defect in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Pulmonary disease accounts for over 90% of the morbidity and mortality associated with the disease. Conventionally, CF treatment has focused on symptomatic therapy. AREAS COVERED: In the past, the emphasis for the development of CF...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biological Research and Disease Studies
• Share to Biotechnology and Related Fields
• Share to Cystic Fibrosis Research Advances